Skip to main content

Table 2 BRG1 is frequently lost in melanomas

From: The chromatin remodelling factor BRG1 is a novel binding partner of the tumor suppressor p16INK4a

  BRM p16INK4a BRG1
Primary 83% (19/23) 21% (5/24) 28% (5/18)
Metastatic 78% (21/27) 19% (4/21) 35% (7/20)
Total 80% (40/50) 20% (9/45) 32% (12/38)
  1. Immunohistological detection of BRG1, p16INK4a and BRM in primary and metastatic melanomas showing the proportion of samples with detectable positive staining.